Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Non-invasive Measurement of Cardiac Output and Stroke Volume to Assess Risk and Response to Treatment in Patients With PAH or CTEPH

NCT05618093 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT05618093
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05618093 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Non-invasive Measurement of Cardiac Output and Stroke Volume to Assess Risk and Response to Treatment in Patients With PAH or CTEPH
Lead sponsor
University of California, Los Angeles
Phase
Not applicable
Overall status
Withdrawn
Start date
March 2, 2023
Completion date
February 26, 2024
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic thromboembolic pulmonary hypertension, pulmonary arterial hypertension